this document is also helpful:
www.biomanufacturing.org/ppt/BIOMAN2011_Keynote_Landeen.ppt
it's been awhile since I reviewed the applications of ReCell, but if it tests well for DFUs (and perhaps also VLUs), then you get the feeling AVH could squash the likes of Advanced BioHealing/Shire in this diabetic ulcer market - but for now TIS has been doing all the hard yards with ulcers, and producing exceptional results and data, so AVH has a lot of catch-up to do before they can begin to nudge TIS/Shire out of this ulcer market - for now TIS remain the only legitimate commercial threat to Shire/ABH, sufficient for a takeover imo
good luck
this document is also...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.02 |
Change
-0.010(0.33%) |
Mkt cap ! $212.6M | |||
| Open | High | Low | Value | Volume |
| $3.05 | $3.12 | $3.01 | $489.6K | 159.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3202 | $3.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.04 | 4230 | 1 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| AVH (ASX) Chart |